EPB235 | Resistance mutations in the HIV integrase coding region among INSTI-naïve pregnant women in Argentina: a baseline survey | E-poster | Resistance to ART |
EPB236 | Transmitted HIV-1 drug resistance in a RAPID ART initiation cohort Panama 2018'2020 | E-poster | Resistance to ART |
EPB237 | Factors associated with Antiretroviral therapy failure among persons living with HIV in Zambia, 2013'2020 ' A retrospective cohort study | E-poster | Resistance to ART |
EPB238 | Temporal trends of pediatric HIV drug resistance and subtype in Brazil (2009-2020) | E-poster | Resistance to ART |
EPB239 | Resistance analysis of long-acting lenacapavir in treatment-naïve people with HIV at 54 weeks | E-poster | Resistance to ART |
EPB240 | Resistance analysis of long-acting Lenacapavir in highly treatment-experienced people with HIV after 52 weeks of treatment | E-poster | Resistance to ART |
EPB241 | Minimal acquired resistance to dolutegravir and bictegravir in patients failing third-line ART in South Africa | E-poster | Resistance to ART |
EPB242 | HIV genotypic drug resistance testing outcomes using Dry Blood Spot samples from patients failing second-line antiretroviral therapy and attending routine care in 3 rural districts of Zimbabwe | E-poster | Resistance to ART |
EPB243 | Frequency of virologic factors possibly associated with CAB/RPV LAI failure | E-poster | Resistance to ART |
EPB244 | Drug resistance in children with HIV in the Democratic Republic of Congo, Equatorial Guinea and Panama | E-poster | Resistance to ART |